Recent Finacing
Recent Raise
Arrivo BioVentures develops small-molecule therapeutics in Morrisville, NC, advancing SP-624 (SIRT6 activator) for major depressive disorder and RABI-767 (pancreatic lipase inhibitor) toward Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Arrivo.
